We are live on ! Find out more
IMGN

Immunogen Inc
IMGN

Delisted

IMGN was delisted on the 9th of February, 2024.

Back to rankings

204 hedge funds and large institutions have $1.1B invested in Immunogen Inc in 2018 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 59 increasing their positions, 69 reducing their positions, and 37 closing their positions.

New
Increased
Maintained
Reduced
Closed

66% more capital invested

Capital invested by funds: $666M → $1.1B (+$438M)

19% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 37

2% more funds holding

Funds holding: 200 → 204 (+4)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

14% less repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 69

68% less call options, than puts

Call options by funds: $8.85M | Put options by funds: $27.5M

Holders
204
Holders Change
+4
Holders Change %
+2%
% of All Funds
4.68%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
44
Increased
59
Reduced
69
Closed
37
Calls
$8.85M
Puts
$27.5M
Net Calls
-$18.6M
Net Calls Change
-$20.2M

Top Buyers

Rank Fund Capital Flow
1
Capital Research Global Investors
Capital Research Global Investors
California
+$54.4M
2
Renaissance Technologies
Renaissance Technologies
New York
+$36.7M
3
PC
PointState Capital
New York
+$16.5M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$8.79M
5
Goldman Sachs
Goldman Sachs
New York
+$6.89M

Top Sellers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
-$16.4M
2
ClearBridge Investments
ClearBridge Investments
New York
-$14.7M
3
O
OrbiMed
New York
-$13.1M
4
Millennium Management
Millennium Management
New York
-$12.9M
5
RG
Redmile Group
California
-$11.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
CHP
176
Cable Hill Partners
Oregon
$6K – – –
FMA
177
FNY Managed Accounts
New York
$6K +$2.27K +230 +58%
IIC
178
Integrated Investment Consultants
Michigan
$6K +$5.81K +588 New
AIM
179
Advantage Investment Management
Iowa
$5K – – –
BWA
180
Burt Wealth Advisors
Maryland
$5K – – –
SPIA
181
Steward Partners Investment Advisory
New York
$5K +$642 +65 +13%
S
182
SignatureFD
Georgia
$5K +$4.93K +499 New
BAM
183
Bruderman Asset Management
New York
$5K +$4.94K +500 New
PNC Financial Services Group
184
PNC Financial Services Group
Pennsylvania
$4K -$326 -33 -9%
LJHT
185
Laurie J. Hall Trustee
$4K – – –
CAW
186
Cornerstone Advisors (Washington)
Washington
$3K – – –
AssetMark Inc
187
AssetMark Inc
California
$2K – – –
CFA
188
Carroll Financial Associates
North Carolina
$2K – – –
CIBC Private Wealth Group
189
CIBC Private Wealth Group
Georgia
$2K – – –
HMS
190
Hanseatic Management Services
New Mexico
$2K +$1.75K +177 New
TC
191
Trilogy Capital
California
$2K +$1.88K +190 New
IBOK
192
Independence Bank of Kentucky
Kentucky
$2K +$1.98K +200 New
HNB
193
Huntington National Bank
Ohio
$2K +$2.04K +206 New
FHA
194
First Horizon Advisors
Tennessee
$1K – – –
FWM
195
Focused Wealth Management
New York
$1K – – –
GWM
196
Geneos Wealth Management
Colorado
$1K – – –
GFP
197
Gryphon Financial Partners
Ohio
$1K – – –
SSB
198
Sandy Spring Bank
Maryland
$1K – – –
OIA
199
OneDigital Investment Advisors
Kansas
$1K +$148 +15 +41%
RCAG
200
Rehmann Capital Advisory Group
Michigan
$1K +$474 +48 New
6 7
8
9 10

IMGN Hedge Fund Activity: Q1 2018 in Review

204 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q1 2018, worth a combined $1.1B — up 66% from $666M a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new IMGN positions and 37 closed out — a net gain of 7 holders — while 59 added to existing stakes and 69 trimmed.

The largest buyer was Capital Research Global Investors, opening a new position worth an estimated $54.4M. The largest seller was Baker Bros. Advisors, exiting entirely with an estimated $16.4M sold.

  • 204 institutional investors held Immunogen Inc (IMGN) as of Q1 2018, up from 200 in Q4 2017.
  • Funds reported $1.1B of Immunogen Inc stock for Q1 2018, up 66% quarter-over-quarter.
  • 44 funds opened new Immunogen Inc positions in Q1 2018 and 37 closed out, a net change of +7 holders.
  • The largest Immunogen Inc buyer in Q1 2018 was Capital Research Global Investors, an estimated $54.4M added.
  • The largest Immunogen Inc seller in Q1 2018 was Baker Bros. Advisors, an estimated $16.4M sold.

Based on aggregated 13F filings for Q1 2018.